Developer docs
API playgroundTry for free, no card

Search company profiles

Eldan Neopharm Group

Full company profile

uuid004bb3t

Namestring
Eldan Neopharm Group
Websiteurl
eldan.biz
Company typeenum
Private
Founded yearint
1960
Descriptiontext

Eldan Neopharm Group is an Israeli company specializing in the import, sales, and servicing of medical devices and equipment. Headquartered in Petah Tikwah, the firm operates as a privately-held distribution and service provider within the Israeli healthcare market, working with medical device OEMs to bring products into Israel and support them post-sale.

The company's business model rests on three reinforcing activities: importing medical devices from international manufacturers, selling them to Israeli healthcare providers, and providing ongoing servicing and maintenance for the installed base. Founded in 1960, Eldan Neopharm Group has operated for over six decades under consistent ownership and a single CEO (Tal Rabinovich), with a workforce of 51-100 employees. This positions the company as a mid-sized specialized distributor rather than a mass-market medical supplies wholesaler; its scope combines capital equipment import with the recurring aftermarket service revenue that medical device servicing typically generates.

The underlying business mechanics are conventional distribution: revenue is generated through device sales margins plus service contracts, calibration, and parts replacement for installed equipment. The company operates from a single disclosed location in Petah Tikwah and serves the Israeli market; no information on geographic footprint beyond Israel, customer segmentation, product portfolio, pricing model, or supplier relationships is available in the provided data. Source pages other than the company name and leadership entry returned loading/verification messages without substantive content, limiting visibility into operational detail.

Short descriptiontext

Eldan Neopharm Group is an Israeli privately-held company, founded in 1960 and headquartered in Petah Tikwah, that imports, sells, and services medical devices and equipment for the Israeli healthcare market.

Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPetah Tikwah, Israel
HQ citystring
Petah Tikwah
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
medical devices, medical equipment, medical device distribution, medical equipment servicing, healthcare imports
Industry1 code
1OTC Medicines & Consumer Health Products Distribution
CodeCRAOAHABPrimaryYes
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Medical Devices Distribution
Social media profiles1 record
Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Eldan Neopharm Group specializes in the import, sales, and servicing of medical devices and equipment for the Israeli healthcare market. The company supplies imported medical hardware to healthcare providers and offers accompanying after-sales servicing. Its portfolio supports healthcare organizations seeking reliable access to medical devices combined with lifecycle maintenance support.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Medical Devices and Equipment Import and Sales
CategoryMedical Devices
Description

Importation and sale of medical devices and equipment to healthcare providers in Israel. The offering covers the supply of physical medical hardware for clinical and institutional use.

2Medical Equipment Servicing and Maintenance
CategoryMedical Equipment Services
Description

After-sales servicing and maintenance for the medical devices and equipment sold to healthcare customers, supporting equipment lifecycle and uptime.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers8 records
TypeBroad incumbent
Description

Large-scale pharmaceutical and medical-surgical distributor. Comparable distribution model to Eldan Neopharm's import-and-sell role, with broader portfolio and US-centric footprint.

TypeBroad incumbent
Description

Major US-listed medical product distributor serving hospitals, pharmacies and clinical labs. Comparable to Eldan Neopharm's medical device distribution role, though much larger and broader in scope.

TypeDirect peer
Description

Distributor of medical and dental products with after-sales service and equipment support. Closely comparable in customer base (clinics, practitioners) and in combined distribution-plus-service model.

TypeDirect peer
Description

Specialised distributor of medical-surgical supplies to hospitals and healthcare providers, with growing patient-direct and supply-chain services — a structurally similar medical-device distribution business.

TypeDirect peer
Description

Global distributor of medical, dental and healthcare products with a strong after-sales service and equipment-installation business — directly aligned with Eldan Neopharm's import, sales and servicing model.

TypeBroad incumbent
Description

Israel's flagship healthcare company and a natural domestic anchor peer — relevant given Eldan Neopharm's Israeli base and the Neopharm (pharmaceutical distribution) heritage, though operating in pharma rather than medical devices.

TypeEmerging player
Description

Provider of medical imaging and healthcare IT equipment that is frequently distributed through local partners in markets like Israel; a likely upstream principal relationship for a medical-device distributor such as Eldan Neopharm.

TypeDirect peer
Description

One of the largest privately-held medical supply distributors and manufacturers globally. Directly comparable as a medical device/equipment distributor with servicing capabilities targeting healthcare providers.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eldan Neopharm Group

Medical Devices Distributioneldan.biz

Eldan Neopharm Group is an Israeli privately-held company, founded in 1960 and headquartered in Petah Tikwah, that imports, sells, and services medical devices and equipment for the Israeli healthcare market.

What Eldan Neopharm Group does

Eldan Neopharm Group is an Israeli company specializing in the import, sales, and servicing of medical devices and equipment. Headquartered in Petah Tikwah, the firm operates as a privately-held distribution and service provider within the Israeli healthcare market, working with medical device OEMs to bring products into Israel and support them post-sale.

The company's business model rests on three reinforcing activities: importing medical devices from international manufacturers, selling them to Israeli healthcare providers, and providing ongoing servicing and maintenance for the installed base. Founded in 1960, Eldan Neopharm Group has operated for over six decades under consistent ownership and a single CEO (Tal Rabinovich), with a workforce of 51-100 employees. This positions the company as a mid-sized specialized distributor rather than a mass-market medical supplies wholesaler; its scope combines capital equipment import with the recurring aftermarket service revenue that medical device servicing typically generates.

The underlying business mechanics are conventional distribution: revenue is generated through device sales margins plus service contracts, calibration, and parts replacement for installed equipment. The company operates from a single disclosed location in Petah Tikwah and serves the Israeli market; no information on geographic footprint beyond Israel, customer segmentation, product portfolio, pricing model, or supplier relationships is available in the provided data. Source pages other than the company name and leadership entry returned loading/verification messages without substantive content, limiting visibility into operational detail.

Eldan Neopharm Group firmographics

Firmographics
Name
Eldan Neopharm Group
Website
https://eldan.biz
Company type
Private
Founded year
1960
Headcount range
51–100 employees
Short description
Eldan Neopharm Group is an Israeli privately-held company, founded in 1960 and headquartered in Petah Tikwah, that imports, sells, and services medical devices and equipment for the Israeli healthcare market.
Ownership category
akta.pro rank

Eldan Neopharm Group industry classification

Industry
Product category
Medical Devices Distribution
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

Keywords

  • Medical devices
  • Medical equipment
  • Medical device distribution
  • Medical equipment servicing
  • Healthcare imports

Where Eldan Neopharm Group is headquartered

Location

Headquarters

HQ city
Petah Tikwah
HQ country
Israel
HQ region
Middle East

Markets served

Eldan Neopharm Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Others

Eldan Neopharm Group product offering

Product offering

Core offering

Eldan Neopharm Group specializes in the import, sales, and servicing of medical devices and equipment for the Israeli healthcare market. The company supplies imported medical hardware to healthcare providers and offers accompanying after-sales servicing. Its portfolio supports healthcare organizations seeking reliable access to medical devices combined with lifecycle maintenance support.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Devices and Equipment Import and Sales Importation and sale of medical devices and equipment to healthcare providers in Israel. The offering covers the supply of physical medical hardware for clinical and institutional use.
  • Medical Equipment Servicing and Maintenance After-sales servicing and maintenance for the medical devices and equipment sold to healthcare customers, supporting equipment lifecycle and uptime.

Companies that use Eldan Neopharm Group

Customer profile

Ideal customer profiles1 record

Eldan Neopharm Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Eldan Neopharm Group partnerships and signals

Strategic signal

Recent moves1 record

Eldan Neopharm Group competitors and assessment

Company assessment

Broad incumbents

  • McKesson: Large-scale pharmaceutical and medical-surgical distributor. Comparable distribution model to Eldan Neopharm's import-and-sell role, with broader portfolio and US-centric footprint.
  • Cardinal Health: Major US-listed medical product distributor serving hospitals, pharmacies and clinical labs. Comparable to Eldan Neopharm's medical device distribution role, though much larger and broader in scope.
  • Teva Pharmaceutical Industries: Israel's flagship healthcare company and a natural domestic anchor peer — relevant given Eldan Neopharm's Israeli base and the Neopharm (pharmaceutical distribution) heritage, though operating in pharma rather than medical devices.

Direct peers

  • Patterson Companies: Distributor of medical and dental products with after-sales service and equipment support. Closely comparable in customer base (clinics, practitioners) and in combined distribution-plus-service model.
  • Owens & Minor: Specialised distributor of medical-surgical supplies to hospitals and healthcare providers, with growing patient-direct and supply-chain services — a structurally similar medical-device distribution business.
  • Henry Schein: Global distributor of medical, dental and healthcare products with a strong after-sales service and equipment-installation business — directly aligned with Eldan Neopharm's import, sales and servicing model.
  • Medline Industries: One of the largest privately-held medical supply distributors and manufacturers globally. Directly comparable as a medical device/equipment distributor with servicing capabilities targeting healthcare providers.

Emerging players

  • Agfa-Gevaert (HealthCare IT / Digital Print): Provider of medical imaging and healthcare IT equipment that is frequently distributed through local partners in markets like Israel; a likely upstream principal relationship for a medical-device distributor such as Eldan Neopharm.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

Eldan Neopharm Group social profiles

Digital presence

Eldan Neopharm Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eldan Neopharm Group leadership team

Management profile

Number of profiles

Profiles1 record

Eldan Neopharm Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eldan Neopharm Group M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eldan Neopharm Group

What does Eldan Neopharm Group do?

Eldan Neopharm Group specializes in the import, sales, and servicing of medical devices and equipment for the Israeli healthcare market. The company supplies imported medical hardware to healthcare providers and offers accompanying after-sales servicing. Its portfolio supports healthcare organizations seeking reliable access to medical devices combined with lifecycle maintenance support.

When was Eldan Neopharm Group founded?

Eldan Neopharm Group was founded in 1960. It employs 51 to 100 people.

Where is Eldan Neopharm Group based?

Eldan Neopharm Group is headquartered in Petah Tikwah, Israel, in the Middle East region.

Who are Eldan Neopharm Group's main competitors?

Broad incumbents on record are McKesson, Cardinal Health and Teva Pharmaceutical Industries. Direct peers are Patterson Companies, Owens & Minor, Henry Schein and Medline Industries. Agfa-Gevaert (HealthCare IT / Digital Print) is listed as an emerging player.

Does Eldan Neopharm Group have an API?

No public API is recorded for Eldan Neopharm Group.

What industry is Eldan Neopharm Group in?

Eldan Neopharm Group's product category is Medical Devices Distribution. Its primary akta.pro industry code is CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireFIZE Medical Secures Investment and Expands Israeli Distribution Through Eldan, a Neopharm Group CompanyFIZE Medical, a medical technology company specializing in fluid management solutions for critically ill patients, has secured an investment and entered into an exclusive distribution partnership with Eldan, a member of Neopharm Group, for the Israeli market. The partnership will support FIZE Medical's next stage of growth while expanding the local presence of its FIZE kUO system, which has already monitored more than 20,000 patients in leading hospitals worldwide. This collaboration represents a strategic expansion of FIZE Medical's global commercialization efforts and Neopharm Group's healthcare portfolio in medical technology.LinkedIn#medicaltechnology #cardiology #interventionalradiology #veravanti #sfe #medtech #endovascular #innovation #angioscopy #medicalinnovation #interventionalist #innovation #medicaldevices…FIZE Medical announced a collaboration with Eldan by Neopharm to expand the reach of its urine-output monitoring technology in ICUs, along with securing investment and expanding distribution in Israel. Lumendi announced that its DiLumen devices are now available in Europe, with CE certification confirming EU compliance, and Lumendi aims to expand its market presence. Artrya reported strong quarterly results including FDA clearance for Salix Coronary Anatomy, a new CEO, an oversubscribed capital raise, and ongoing progress on the SAPPHIRE study and US expansion.WebWireMission Bio Brings the Power of Single-Cell Genomics Worldwide with Key Partnerships in Europe and AsiaMission Bio announced distribution agreements with Eldan, Bucher Biotec, and Imperial Life Sciences to expand its Tapestri single-cell multi-omics platform in Europe and Asia. The company projects the global single-cell multi-omics market to exceed $5 billion in five years, with the broader genomics market reaching over $27 billion.PR NewswireMedicinal Genomics Partners with Eldan to Distribute its Cannabis Testing and Genomics Solutions to the Israeli MarketMedicinal Genomics Corp. signed a distribution agreement with Eldan to supply its cannabis testing and genomics solutions in the Israeli market. This partnership grants Eldan access to MGC's proprietary platforms for detecting cannabis genes, microorganisms, and pathogens, aiming to improve production standards and safety. The move supports MGC's broader global expansion strategy as Israel normalizes its cannabis industry.